Neurobiological aspects of human immunodeficiency virus infection: Neurotoxic mechanisms

Progress in Neurobiology

Volumn 54, Issue 1, 1998, Pages 19-33

  Nath, Avindra ^a   Geiger, Jonathan ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR ANTAGONIST; ARACHIDONIC ACID; CYCLOHEXIMIDE; DIZOCILPINE; EXCITATORY AMINO ACID; FLUPIRTINE; GLYCOPROTEIN GP 120; KAINIC ACID RECEPTOR ANTAGONIST; KYNURENIC ACID; MEMANTINE; MEPACRINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTOXIN; NIFEDIPINE; NIMODIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; QUINOLINIC ACID; QUISQUALIC ACID; RILUZOLE; TETRODOTOXIN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VIRUS PROTEIN;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ASTROCYTE; DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE BINDING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; REVIEW; VIRUS INFECTION;

EID: 0031974964     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(97)00053-1     Document Type: Article

References (149)

1. Adamson D. C., Wildemann B., Masayuki S., Glass J. D., McArthur J. C., Christov W. I., Dawson T. M., Dawson V. L. Immunologic NO synthase: Elevation in severe AIDS dementia and induction by HIV-1 gp41. Science. 274:1996;1917-1921.
2. Aggoun-Zouaoui D., Charriaut-Marlangue C., Rivers S., Jorquera I., Ben-Ari Y., Represa A. The HIV-1 envelope protein gp120 induces neuronal apoptosis in hippocampal slices. NeuroReport. 7:1996;433-436.
3. Aloisi F., Care A., Borsellino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G., Peschle C. Production of lymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumor necrosis factor-alpha. J. Immunol. 149:1992;2358-2366.
4. Ascher P., Novak L. Quisqualate- and kainate-activated channels in mouse central neurons in culture. J. Physiol. (Lond.). 399:1988;227-245.
5. Bagasra O., Lavi E., Bobroski L. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS. 10:1996;573-585.
6. Barks J. D., Sun R., Malinak C., Silverstein F. S. gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats. Expl Neurol. 132:1995;123-133.
7. Barks J. D., Liu X.-U., Sun R. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience. 76:1997;397-409.
8. Bennett B. A., Rusyniak D. E., Hollingsworth C. K. HIV-1 gp120-induces neurotoxicity to midbrain dopamine cultures. Brain Res. 705:1995;168-176.
9. Benos D. J., Hahn B. H., Bubien J. K., Ghosh S. K., Mashburn A. H., Chaikin M. A., Shaw G. M., Benveniste E. N. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: Implications for AIDS dementia complex. Proc. natn. Acad. Sci. U.S.A. 91:1994;494-498.
10. + exchange in astrocytes. J. Biol. Chem. 269:1994;13811-13816.
11. Berger E. A., Lifson J. D., Eiden L. E. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc. natn. Acad. Sci. U.S.A. 88:1991;8082-8086.
12. Bernardo A., Patrizio M., Levi G., Petrucci T. C. Human immunodeficiency virus protein gp120 interfers with β-adrenergic receptor-mediated protein phosphorylation in cultured rat cortical strocytes. Cell. Molec. Neurobiol. 14:1994;159-173.
13. 2+ in hippocampal neurons. Neuron. 9:1992;285-294.
14. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 335:1988;639-642.
15. + T cell infiltration. J. Immunol. 149:1992;2954-2960.
16. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J. Neurosci. 14:1994;187-197.
17. Brorson J. R., Manzolillo P. A., Gibbons S. J., Miller R. J. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J. Neurosci. 15:1995;4515-4524.
18. Bubien J. K., Beneveniste E. N., Benos D. HIV-gp120 activates large-conductance apamin-sensitive potassium channels in rat astrocytes. Am. J. Physiol. 268:1995;C1440-C1449.
19. Bukrinsky M. I., Nottet H. S., Schmidtmayerova H., Dubrovsky L., Flanagan C. R., Mullins M. E., Lipton S. A., Gendelman H. E. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-1-associated neurological disease. J. Exp. Med. 181:1995;735-745.
20. Cheng B., Christakos S., Mattson M. P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 12:1994;139-153.
21. Cheng, J., Nath, A. and Knudsen, B. Neuroexcitatory properties of human immunodeficiency virus type 1 tat protein. Neuroscience. (in press).
22. Chung I. L., Benveniste E. N. Tumor necrosis factor-α production by astrocytes. Induction by lipopolysaccharide, IFN-γ, and IL-1β J. Immunol. 144:1990;2999-3007.
23. i increases in a glial cell subpopulation. Eur. Neurosci. 5:1993;1711-1718.
24. Clark G. D., Happel L. T., Zorumski C. F., Bazan N. G. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron. 9:1992;1211-1216.
25. Conant K., Ma M., Nath A., Major E. O. Extracellular human immunodeficiency virus type-1 Tat protein is associated with an increase in both NF-κB binding and protein kinase C activity in primary human astrocytes. J. Virol. 70:1996;1384-1389.
26. Corasaniti M. T., Melino G., Navarra M., Garaci E., Finazzi-Agro A., Nistico G. Death of cultured human neuroblastoma cells induced by HIV-1 gp120 is prevented by NMDA receptor antagonists and inhibitors of nitric oxide and cyclooxygenase. Neurodegeneration. 4:1995;315-321.
27. Daniell E. Genome structure of incomplete particles of adenovirus. J. Virol. 19:1976;685-708.
28. Dawson V., Dawson T. M., Uhl G. R., Snyder S. H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc. natn. Acad. Sci. U.S.A. 90:1993;3256-3259.
29. Diop A. G., Lesort M., Esclaire F., Sindou P., Couratier P., Hugon J. Tetrodotoxin blocks HIV coat protein (gp120) toxicity in primary neuronal cultures. Neurosci. Lett. 165:1994;187-190.
30. Diop A. G., Lesort M., Esclaire F., Dumas M., Hugon J. Calbindin D28K-containing neurons, and not HSP70-expressing neurons, are more resistant to HIV-1 envelope (gp120) toxicity in cortical cell cultures. J. Neurosci. Res. 42:1995;252-258.
31. Drejer J., Larsson O. M., Schousboe A. Characterization of uptake and release processes for D- and L-aspartate in primary cultures from astrocytes and cerebellar granule cells. Neurochem. Res. 8:1983;231-243.
32. Ensoli B., Buonaguro L., Barilari G. Release, uptake and effects of extracellular HIV-1 tat protein on cell growth in viral transactivation. J. Virol. 67:1993;277-287.
33. Epstein L. G., Gendelman H. E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenic mechanisms. Ann. Neurol. 33:1993;429-436.
34. Estes M. K., Graham D. Y., Mason B. B. Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J. Virol. 39:1981;879-888.
35. Everall I. P., Hudson L., Al-Sarraj, Honavar M., Lantos P., Kerwin R. Decreased expression of AMPA receptor messenger RNA and protein in AIDS: a model of HIV-assocaited neurotoxicity. Nature Med. 1:1995;1774-1778.
36. Fine S. M., Angel R. A., Perry S. W., Epstein L. G., Gelbard H. A. Tumor necrosis factor α inhibits glutamate uptake by primary human astrocytes. J. Biol. Chem. 271:1996;15303-15306.
37. Foga I. O., Nath, A., Hasinoff, B. B. and Geiger, J. D. Antioxidants and dipyridamole inhibit human immunodeficiency virus type-1 gp120-induced free radical based oxidative damage to human monocytoid cells. J. AIDS Hum. Retrovir. (in press).
38. Garthwaite G., Garthwaite J. AMPA neurotoxicity in rat cerebellar and hippocampal slices: histological evidence for three mechanisms. Eur. J. Neurosci. 3:1991;715-728.
39. Gelbard H. A., Nottet H. S. L. M., Swindells S., Jett M., Dzenko K. A., Genis P., White R., Wang L., Choi Y., Zhang D., Lipton S. A., Tourtellotte W. W., Epstein L. G., Gendelman H. E. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J. Virol. 68:1994;4628-4635.
40. Genis P., Jett M., Bernton E., Boyle T., Gelbard H. A., Dzenko K., Keane R. W., Resnick L., Mizrachi Y., Volsky D. J. Cytokines and arachidonic acid metabolites are produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implication for the neuropathogenesis of HIV disease. J. Exp. Med. 176:1992;1703-1718.
41. Ghosh A., Greenberg M. E. Calcium signaling in neurons: Molecular mechanisms and cellular consequences. Science. 268:1995;239-247.
42. Giulian D., Vaca K., Noonan C. A. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science. 250:1990;1593-1596.
43. Giulian D., Yu J., Li X., Tom D., Li J., Wendt E., Lin S., Schwarcz R., Noonan C. Study of receptor-mediated neurotoxins released by HIV-1-Infected mononuclear phagocytes found in human brain. J. Neurosci. 16:1996;3139-3153.
44. Gray F., Lescs M. C., Keohane C., Paraire F., Marc B., Durigon M., Cherardi R. Early brain changes in HIV infection: Neuropathological study of 11 HIV seropositive. Non-AIDS cases. J. Neuropathol. Exp. Neurol. 51:1992;177-185.
45. Harouse J. M., Bhat S., Spitalnik S. L., Laughlin M., Stefano K., Silberberg D. H., Gonzalez-Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 253:1991;320-323.
46. Harrison, M. J. G. and McArthur, J. (1995) HIV associated dementia complex. In: AIDS and Neurology, pp. 31-64. Eds M. J. G. Harrison and J. McArthur. Churchill Livingstone: New York.
47. Haughey N., Nath A., Geiger J. D. HIV-1 regulatory protein Tat and Tat fragments induced calcium in human brain cells. Can. J. Inf. Dis. 6(Suppl B):1995;14.
48. Hayman M., Arbuthnott G., Harkiss G. Neurotoxicity of peptide analogues of the transactivating protein tat from maedi-visna virus and human immunodeficiency virus. Neuroscience. 53:1993;1-6.
49. Heyes M. P., Brew B. J., Martin A. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:1991;202-209.
50. Heyes M. P., Saito K., Markey S. P. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem. J. 283:1992;633-635.
51. Hogan M., Vogen S. N. Production of TNF by rIFN-δ-primed CC3HH/HeJ (Lpsd) macrophages requires the presence of lipid-A-associated proteins. J. Immunol. 141:1988;4196-4199.
52. 2+ responses to HIV-1 gp120 in cultured human fetal brain cells. J. Neurochem. 69:1997;S157.
53. Janssen E. S., Wanyanwu O. C., Selik R. M., Stehr-Green J. K. Epidemiology of human immunodeficiency encephalopathy in the United States. Neurology. 42:1992;1472-1476.
54. Jonas P., Sakmann B. Glutamate receptor channels in isolated patches from CA1 and CA3 pyramidal cells of rat hippocampal slices. J. Physiol. (Lond.). 455:1992;143-171.
55. Kim J. P., Choi D. W. Quinolinate neurotoxicity in cortical cell culture. Neuroscience. 25:1987;423-432.
56. Koda P., He K., Zack J. A., Kitchen S., Peacock W., Friend I., Tran T., Yashar S. S., Merrill J. E. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med. 182:1995;941-951.
57. Koenig S., Gendelman H. E., Orenstein J. M., Dal-Canto M. C., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 233:1986;1089-1093.
58. 2+ and induces a depolarization in cultured astroglial cells. Brain. 119:1996;2021-2027.
59. Kolson D. L., Collman R., Hrin R., Balliet J. W., Laughlin M., McGann K. A., Debouck C., Gonzales-Scarano F. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation. J. Gen. Virol. 75:1994;1927-1934.
60. Kolson D. L., Buchhalter J., Collman R., Hellmig B., Farrell C. F., Debouck C., Gonzales-Scarano F. HIV-1 tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Res. Hum. Retroviruses. 9:1993;677-685.
61. Kure K., Lyman W., Weidenheim K., Dickson D. Cellular localization of HIV antigen in subacute AIDS encephalitis using an improved double labelling immunohistochemical method. Am. J. Pathol. 136:1990;1085-1092.
62. Lafortune L., Nalbantoglu J., Antel J. P. Expression of tumor necrosis factor α (TNFα) and interleukin 6 (IL-6) mRNA in adult human astrocytes: Comparison with adult microglia and fetal astrocytes. J. Neuropathol. Exp. Neurol. 55:1996;515-521.
63. i homeostasis and induce neurotoxicity in human embryonic neurons. Eur. J. Neurosci. 7:1995;2285-2293.
64. Levi G., Patrizio M., Bernardo A., Petrucci T. C., Agresti C. Human immunodeficiency virus coat protein gp120 inhibits the β-adrenergic regulation of astroglial and microglial functions. Proc. natn. Acad. Sci. U.S.A. 90:1993;1541-1545.
65. Levy, J. A. (1994) Detection and quantitation of virus activity. In: Virology, Eds J. A. Levy, H. Frankel-Conrad and R. A. Owens, pp. 411-412. Prentice-Hall, New Jersey.
66. Lipton S. A., Sucher N. J., Kaiser P. K., Dreyer E. B. Synergistic effects of HIV coat protein and NMDA receptor mediated neurotoxicity. Neuron. 7:1991;111-118.
67. Lipton S. A. Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann. Neurol. 33:1993;227-228.
68. Lipton S. A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev. Neurosci. 16:1994;145-151.
69. Lipton S. A. HIV displays its coat of arms. Nature. 367:1994;113-114.
70. Ma M., Geiger J. D., Nath A. Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope gp120 on human fetal astrocytes. J. Virol. 68:1994;6824-6828.
71. Ma M., Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficienty virus type 1 in brain cells. J. Virol. 71:1997;2495-2499.
72. Mabrouk K., Van-Rietschoten J., Vives E., Darbon H., Rochat H., Sabatier J. M. Lethal neurotoxicity in mice of the basic domains of HIV and SIV Rev proteins. FEBS Lett. 289:1991;13-17.
73. Magnuson D. S. K., Knudsen B. E., Geiger J. D., Brownstone R. M., Nath A. Human immunodeficiency virus type 1 Tat activates non-N-methyl-D-asparatate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37:1995;373-380.
74. Marcheselli V. L., Bazan N. G. Platelet activating factor (PAF) enhances glutamic acid release in the retina through a presynaptic receptor. Invest. Ophthalmol. Vis. Sci. 34:1993;1048-1053.
75. Masliah E., Ge N., Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10:1996;57-67.
76. Mayer M. L, Westbrook G. L. Mixed-agonist action of excitatory amino acids on mouse spinal cord neurons under voltage clamp. J. Physiol. (Lond.). 354:1984;29-53.
77. McArthur J. C., Hoover D. R., Bacellar H. Dementia in AIDS patients. Neurology. 43:1993;2245-2252.
78. McArthur J. C., Becker P. S., Parisi J. E., Trapp B., Selnes O. A., Cornblath D. R., Balakrishnan J., Griffin J. W., Price D. Neuropathological changes in early HIV-1 dementia. Ann. Neurol. 26:1989;681-684.
79. Merrill J. E., Chen I. S. Y. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5:1991;2391-2397.
80. Meucci O., Miller R. J. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: Protective action of TGF-β1. J. Neurosci. 16:1996;4080-4088.
81. Meyers, G. (1993) Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Almos, New Mexico.
82. Miller B., Sarantis M., Traynelis S. F., Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature. 355:1992;722-725.
83. Mills E. L., Debets-Ossenkopp Y., Verbrugh H. A., Verhoef J. Initiation of the respiratory burst of human neutrophils by influenza virus. Infect. Immun. 32:1981;1200-1205.
84. Mollace V., Colasanti M., Persichini T., Bagetta G., Lauro G. M., Nistico G. HIV gp120 glycoprotein stimulates the inducible isoform of NO synthase in human cultured astrocytoma cells. Biochem. Biophys. Res. Commun. 194:1993;439-445.
85. Moore J. P., Klasse P. J. Thermodynamic and kinetic analysis of sCD4-binding to HIV-1 virions and of gp120 dissociation. AIDS Res. Hum. Retroviruses. 8:1992;443-450.
86. Mucke L., Masliah E., Campbell I. L. Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. Curr. Top. Microbiol. Immunol. 202:1995;187-205.
87. Nath A., Pauda R. A., Geiger J. D. HIV-1 coat protein gp120-induced increases in levels of intrasnaptosomal calcium. Brain Res. 678:1995;200-206.
88. Nath A., Psooy K., Martin C., Knudsen B., Magnuson D. S. K., Haughey N., Geiger J. D. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70:1996;1475-1480.
89. Nath A., Power C., Geiger J. D. HIV infection in CD4 cells. Prespect. Drug Discovery Design. 5:1996;30-42.
90. Navia B. A., Price R. W. The acquired immunodeficiency virus syndrome dementia complex presenting as the sole manifestation of HIV infection. Archs Neurol. 44:1987;65-69.
91. Navia B. A., Cho E. -S., Petito C. K., Price R. W. The AIDS dementia complex: II Neuropathology. Ann. Neurol. 19:1986;525-535.
92. New D. R., Ma M., Epstein L. G., Nath A., Gelbard H. A. Human immunodeficiency virus type 1 tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3:1997;168-173.
93. Nicotera P., Bonfoco E., Brune B. Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv. Neuroimmunol. 5:1995;411-420.
94. Nosaka T., Takamatsu T., Miyazaki Y., Sano K., Sato A., Kubota S., Sakurai M., Ariumi Y., Nakai M., Fujita S. Cytotoxic activity of rev protein of human immunodeficiency virus type 1 by nucleolar dysfunction. Expl Cell Res. 209:1993;89-102.
95. Notte H. S. L. M., Flanagan E. M., Flanagan C. R., Galbard H. A., Gendelman H. E., Reinhard Jr J. F. The regulation of quinolinic acid in human immunodeficiency virus-infected monocytes. J. Neurovirol. 2:1996;111-117.
96. Nuovo G. J., Gallery F., MacConnell P., Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-α RNA in the central nervous system. Am. J. Pathol. 144:1994;659-666.
97. Oh S. K., Cruikshank W. W., Raina J., Blanchard G. C., Adler W. H., Walker J., Kornfeld H. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J. AIDS. 5:1992;251-256.
98. Okiuno E., Kohler C., Schwarcz R. Rat 3-hydroxyanthranilic acid oxygenase: purification from the liver and immunocytochemical localization in the brain. J. Neurochem. 49:1987;771-780.
99. Okiuno E., Nakamura M., Schwarcz R. Two kynurenine aminotransferases in human brain. Brain Res. 542:1991;307-312.
100. Olafson K., DelBigio M., Peeling J., Jones M., Nath A. Human immunodeficiency virus protein, Tat, causes inflammation, apoptosis and atrophy in rat brain. J. Neurovirol. 2:1996;18.
101. Orsini M. J., Debouck C. M., Webb C. L., Lysko P. G. Extracellular human immunodeficiency virus type 1 Tat protein promotes aggregation and adhesion of cerebellar neurons. J. Neurosci. 16:1996;1546-2552.
102. Parmentier H. K., van Wichen D. F., Meyling R. H. J. G., Goudsmit J., Schuurman H.-J. Epitopes of human immunodeficiency virus regulator proteins tat, nef and rev are expressed in normal human tissue. Am. J. Pathol. 141:1992;1209-1216.
103. Perovic S., Schleger C., Pergande G., Iskric S., Ushijima H., Rytik P., Muller W. E. The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1. Eur. J. Pharmacol. 288:1994;27-33.
104. Peterhans E. Chemiluminescence: an early event in the interaction of sendai and influenza viruses with mouse spleen cells. Virology. 105:1980;445-455.
105. Philippon V., Vellutini C., Gambarelli D., Harkiss G., Arbuthnott G., Metzger D., Roubin R., Filippi P. The basic domain of the lentiviral tat protein is responsible for damages in mouse brain: Involvement of cytokines. Virology. 205:1994;519-529.
106. Pietraforte D., Tritarelli E., Testa U., Minetti M. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leukoc. Biol. 55:1994;175-182.
107. Porter J. T., McCarthy K. D. Astrocytic neurotransmitter receptors in situ and in vivo. Prog. Neurobiol. 51:1997;439-455.
108. Power C., McArthur J. C., Johnson R. T., Griffin D. E., Glass J. D., Perryman S., Chesebro B. Demented and non-demented patients with AIDS differ in brain derived HIV-1 envelope sequences. J. Virol. 68:1994;4643-4669.
109. Pulliam L., Herndier B. G., Tang N. M., McGrath M. S. HIV-1 infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. J. Clin. Invest. 87:1991;503-512.
110. Pulliam L., West D., Haigwood N., Swanson R. A. HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Res. Human Retrovir. 9:1993;439-444.
111. Ranki A., Nyberg M., Ovod V., Haltia M., Elovaara I., Raininko R., Haapasalo H., Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS. 9:1995;1001-1008.
112. Rothman S. M., Olney J. W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:1986;105-111.
113. Rothstein J. D., Jin L., Dykes-Hoberg M., Kuncl R. W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. natn. Acad. Sci. U.S.A. 90:1993;6591-6596.
114. Sabatier J. M., Vives E., Mabrouk K. Evidence for neurotoxic activity of tat from human immunodeficiency vrus type 1. J. Virol. 65:1991;961-967.
115. Saito Y., Sharer L. G., Epstein L. F., Michaels J., Mintz M., Louder M., Golding B. A., Cvetkovich T. A., Blumbert B. M. Overexpression of Nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous system tissues. Neurology. 44:1994;474-481.
116. Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:1989;394-397.
117. Schwartz R., Whetsell W. O. Jr., Mangano R. M. Quinolinic acid: an endogenous metabolite can produce axon sparing lesions in rat brain. Science. 219:1983;316-318.
118. Schwartz M., Solomon A., Lavie V., Ben-Bassat S., Belkin M., Cohen A. Tumor necrosis factor facilitiates regeneration of injured central nervous system axons. Brain Res. 545:1991;334-338.
119. Sharer L. R. Pathology of HIV-1 infection of the central nervous system. A review. J. Neuropathol. Exp. Neurol. 51:1992;3-11.
120. Shatrov V. A., Ratter F., Gruber A., Droge W., Lehmann V. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-κB activation in jurkat cells. AIDS Res. Hum. Retrovir. 12:1996;1209-1216.
121. Sindou P., Couratier P., Esclaire F., Yardin C., Bousseau A., Hugon J. Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzole. J. Neurol. Sci. 126:1994;133-137.
122. Storz J., Rott R., Kaluza G. Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment. Infect. Immun. 31:1981;1214-1222.
123. Talley A. K., Dewhurst S., Perry S. W., Dollard S. C., Gummuluru S., Fine S. M., New D., Epstein L. G., Geldelman H. E., Gelbard H. A. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15:1995;2359-2366.
124. Tardieu M., Hery C., Peudenier S., Boespflug O., Montagnier L. Human immunodeficiency virus type 1-infected cells can destroy human neural cells after cell-to-cell adhesion. Ann. Neurol. 32:1992;11-17.
125. Thali M., Furman C., Helseth E., Repke H., Sodroski J. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. J. Virol. 66:1992;5516-5524.
126. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-193.
127. Toggas S. M., Masliah E., Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res. 706:1996;303-307.
128. Tong G., Shepherd D., Jahr C. E. Synaptic desensitization of NMDA receptors by calcineurin. Science. 267:1995;1510-1512.
129. Tornatore C., Chandra R., Berger J. R., Major E. O. HIV infection of subcortical astrocytes in the pediatric central nervous system. Neurology. 44:1994;481-487.
130. Twyman R. E., Gahring L. C., Spiess J., Rogers S. W. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron. 14:1995;755-762.
131. Tyler K. L, Oberhaus S. M., Clayton G. H., Smith R. L. Apoptosis is a major mechanism of CNS injury in a reovirus-induced experimental model of viral encephalitis. Neurology. 46S:1996;A154.
132. Ushijima H., Nichio O., Klocking R., Perovic S., Muller W. E. Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur. J. Neurosci. 7:1995;1353-1359.
133. Vazeux R., Lacroix-Ciarudo C., Blanche S., Crumont M.-C., Henin D., Gray F., Boccon-Gibod L., Tardieu M. Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am. J. Path. 140:1992;137-144.
134. Walsh J., Todd W. P., Carpenter B. K., Schwarcz R. 4-halo-3-hydroxyanthranilic acids: potent competitive inhibitors of 3-hydroxyanthranilic acid oxygenase in vitro. Biochem. Pharmacol. 42:1991;985-990.
135. Weeks B. S., Lieberman D. M., Johnson B. Neurotoxicity of the human immunodeficiency virus type 1 tat transactivator to PC12 cells requires that tat amino acid 49-58 basic domain. J. Neurosci. Res. 42:1995;34-40.
136. Weissman D., Poli G., Bousseau A., Fauci A. S. A platelet-activating factor antagonist, RP 55778, inhibits cytokine- dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells. Proc. natn. Acad. Sci. U.S.A. 90:1993;2537-2541.
137. Werner T., Ferroni S., Saermark T. HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS. 5:1991;1301-1308.
138. Wesselingh S. L., Power C., Glass J. D. Intracerebral cytokine messenger RNA expression in AIDS dementia. Ann. Neurol. 33:1993;576-582.
139. Wesselingh S. L., Glass J., McArthur J. C., Griffin J. W., Griffin D. E. Cytokine dysregulation in HIV-associated neurological disease. Adv. Neuroimmunol. 4:1994;199-206.
140. Wieraszko A. G., Li G., Kornecki E., Hogan M. V., Ehrlich Y. H. Long-term potentiation in the hippocampus induced by platelet-activating factor. Neuron. 10:1993;553-557.
141. Wiley C., Schrier R. D., Nelson J. A., Lampert P. W., Oldstone M. B. A. Cellular localization of human immunodeficiency virus infection within the brains of acquired immunodeficiency syndrome patients. Proc. natn. Acad. Sci. U.S.A. 83:1986;7089-7093.
142. Wiley C. A., Baldwin M., Achim C. L. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS. 10:1996;843-847.
143. Wilt S. G., Milward E., Zhou J. M., Nagasato K., Patton H., Rusten R., Griffin D. E., O'Connor M., Dubois-Dalcq M. In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37:1995;381-394.
144. Wong G. H. W., Elwell J. H., Oberley L. W., Goeddel D. V. Manganese superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:1989;923-931.
145. Wu P., Price P., Du B., Hatch W. C., Terwilliger E. F. Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. NeuroReport. 7:1996;1045-1049.
146. Wyss-Coray T., Masliah E., Toggas S. M., Rockenstein E. M., Brooker M. J., Lee H. S., Mucke L. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97:1996;789-798.
147. Yeung M. D., Pulliam L., Lau A. S. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS. 9:1995;137-143.
148. Zauli G., Gibellini D., Milani D., Mazzoni M., Borgatti P., La-Placa M., Capitani S. The human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial and neuronal cell lines from death by apoptosis. Cancer Res. 53:1993;4481-4485.
149. Zauli G., Gibellini D., Caputo A., Bassini A., Negrini M., Monne M., Mazzoni M., Capitani S. The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood. 86:1995;3823-3834.